Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Healthcare in India Stories

2011-08-08 06:30:00

NEW YORK, Aug. 8, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), today announced its results for the second quarter ended June 30, 2011. At June 30, 2011, the Company had cash, cash equivalents, interest receivable and investment...

2011-08-03 06:00:00

CALGARY, Aug. 3, 2011 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 31(st) Canaccord Genuity Growth Conference on Wednesday, August 10(th), 2011 at 3:00 p.m. ET. The conference will take place from August 9(th) to 11(th) at the InterContinental Hotel in Boston, MA. A live audio link to the webcast presentation will be available at: http://wsw.com/webcast/canaccord4/oncy/,...

2011-07-09 00:00:32

Investors seeking a portion of the $8 million available in FY 2012 for the State's popular Biotechnology Investment Incentive Tax Credit submitted more than 180 applications online within three minutes July 1, Maryland Department of Business and Economic Development (DBED) Secretary Christian S. Johansson announced today. The online system was launched last year to make the application process easier and more efficient and eliminate the need for investors and biotech firms to line up in...

2011-07-05 06:00:00

CALGARY, July 5, 2011 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY) ("Oncolytics") today announced the appointment of George M. Gill, MD as Chief Medical Officer. He has been Senior Vice President of Clinical Safety and Regulatory Affairs and an officer of Oncolytics since 2002. "Dr. Gill has an outstanding track record, having supported the advancement of more than 20 products - including 11 anti-cancer agents - through the clinical research and regulatory...

2011-06-13 07:00:00

SAN DIEGO, June 13, 2011 /PRNewswire/ -- Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today the hiring of Martin Price as General Counsel and Janna Sipes as Senior Vice President, Regulatory Counsel, Chief Compliance Officer. As Millennium Laboratories General Counsel, Mr. Price will oversee all legal affairs of the company. Howard Appel, Millennium Laboratories' President, said, "We are very pleased...

2011-06-09 04:30:00

DALLAS, June 9, 2011 /PRNewswire/ -- According to a new market research report, 'Global LED Driver IC Market for Display & Lighting Applications (2010 - 2015)', published by MarketsandMarkets (http://www.marketsandmarkets.com), the total global LED Driver IC market is expected to be worth $4,424.0 million by 2015, out of which the display application accounted for the largest share; i.e. 80% of the overall the LED driver IC market. The overall market is expected to record a CAGR of...

2011-06-08 07:00:00

MALVERN, Pa., June 8, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the appointment of Mr. Jonathan B. Lloyd Jones, ACA, MBA, as chief financial officer and vice president of corporate development. Mr. Lloyd Jones joins TetraLogic with over 25 years of corporate development and finance experience. He has led negotiations, valuation and diligence teams that developed and...

2011-06-02 07:00:00

SAN DIEGO, June 2, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that the company's President and CEO Ted Schroeder will present the company's corporate overview on Thursday, June 9, 2011 at 1:30pm Eastern Time (10:30am Pacific Time) during the Jefferies 2011 Global Healthcare Conference at the Grand Hyatt...

2011-06-02 06:00:00

CALGARY, June 2, 2011 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Jeffries 2011 Global Healthcare Conference on Thursday, June 9(th), 2011 at 10:00 a.m. ET. The conference will take place from June 6(th) to 9(th) in New York, NY. A live audio link to the webcast presentation is available at: http://www.wsw.com/webcast/jeff60/oncy/, or on the company's website at...

2011-06-01 07:00:00

EVANSTON, Ill., June 1, 2011 /PRNewswire/ -- Aaron Mitchell, managing principal at global management consulting firm ZS Associates, was named one of the top 25 consultants of 2011 by Consulting Magazine. Mitchell was recognized for directing his consulting team's partnership with a leading biotech firm over several years and during a major, recent product launch. "I feel honored to be named one of the top consultants," said Mitchell, who has more than 10 years of experience with sales,...